Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-23-018361

Chief Financial Officer sold 37,062 shares at $4.75 ($176,119)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-23 Sale : show line 1 in the form 10b5-1 −37,062 $4.75 $176,119 46,120 D
Open-market sales · 37,062 sh · avg $4.75 · $176,119
Loading xslF345X05/doc4.xml…